DeNA Life Science Inc. employee Hiroki Furuhashi talks to members of the media as he stands in front of a scanning device used in the preparation of genetic analysis for the company's direct-to-consumer (DTC) genetic testing service "Mycode" during a media preview in a laboratory at the University of Tokyo's Institute of Medical Science in Tokyo, Japan, on Wednesday, July 9, 2014. DeNA Life Science, the healthcare subsidiary of DeNa, announced today the DTC genetic testing service will be launched in Japan in mid-August. Photographer: Kiyoshi Ota/Bloomberg via Getty Images
Getty Images

Bloomberg Bloomberg